UBS Group
VSEEW

UBS Group’s VSEE HEALTH INC WTS 29 VSEEW Stock Holding History

UBS Group’s Portfolio VSEEW Stock Details VSEEW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54 Buy
1,786
+200
+13% +$8 ﹤0.01% 10184
2026
Q1 		$56 Sell
1,586
-915
-37% -$52 ﹤0.01% 10193
2025
Q4 		$195 Buy
2,501
+1,899
+315% +$202 ﹤0.01% 10117
2025
Q3 		$10 Sell
602
-1,885
-76% -$72 ﹤0.01% 10193
2025
Q2 		$87 Hold
2,487
– – ﹤0.01% 10015
2025
Q1 		$147 Sell
2,487
-525
-17% -$26 ﹤0.01% 9919
2024
Q4 		$151 Sell
3,012
-2,446
-45% -$130 ﹤0.01% 9600
2024
Q3 		$218 Sell
5,458
-942
-15% -$102 ﹤0.01% 9057
2024
Q2 		$1.38K Buy
+6,400
New +$964 ﹤0.01% 8583
2023
Q4 		– Sell
-145
Closed -$3 – 9991
2023
Q3 		$3 Sell
145
-135
-48% -$4 ﹤0.01% 9329
2023
Q2 		$18 Buy
+280
New +$23 ﹤0.01% 8697
2023
Q1 		– Sell
-4,710
Closed -$471 – 10533
2022
Q4 		$471 Sell
4,710
-4,920
-51% -$519 ﹤0.01% 10170
2022
Q3 		$1K Hold
9,630
– – ﹤0.01% 10062
2022
Q2 		$1K Buy
+9,630
New +$1.38K ﹤0.01% 9992

Other funds holding VSEEW

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
QCIG
Quad-Cities Investment Group Davenport, Iowa $278M AUM 22.38% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

UBS Group's VSEEW Position: Q2 2026 in Review

UBS Group increased its VSEE HEALTH INC WTS 29 (VSEEW) stake by 13% in Q2 2026, buying an estimated $8 and bringing the position to 1,786 shares worth $54. The position accounts for ﹤0.01% of the portfolio, ranked #10184.

UBS Group first reported a position in VSEEW in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.38K in Q2 2024. 19 funds tracked by Wall St. Rank hold VSEEW as of Q2 2026.

  • UBS Group held 1,786 shares of VSEE HEALTH INC WTS 29 worth $54 as of Q2 2026.
  • UBS Group bought 200 VSEE HEALTH INC WTS 29 shares in Q2 2026, an estimated $8.
  • VSEE HEALTH INC WTS 29 made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10184 holding.
  • UBS Group first reported a position in VSEE HEALTH INC WTS 29 in Q2 2022 and has held it in 14 quarters since.
  • UBS Group's VSEE HEALTH INC WTS 29 position peaked at $1.38K in Q2 2024.
  • 19 funds tracked by Wall St. Rank held VSEE HEALTH INC WTS 29 as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.